BSX vs RTACU
Boston Scientific Corp (BSX) versus Renatus Tactical Acquisition Corp I (RTACU) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Renatus Tactical Acquisition Corp I (RTACU) is a shell companies company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
RTACU does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. RTACU currently screens at market cap $0.
Not investment advice. Open the BSX and RTACU stock pages for the full models.
Not investment advice.